
RxC Perspectives

Growing AI Applications in Biopharma and Biotech
As technology advances, Artificial Intelligence (AI) is becoming an increasingly useful tool in the pharma and biotech industries. The size of and speed at which AI can analyze data sets is helping companies more efficiently discover, manufacture, and commercialize drugs.


Partnering for Successful Life Cycle Management: 5 Reasons to Seek Outside Help
Pharmaceutical companies with effective Life Cycle Management (LCM) planning typically work with outside partners to develop and execute LCM plans. Working with a third-party partner adds outside thinking and best practices to an organization.


Patient Unmet Needs and Pipeline Developments in Fibromyalgia
Fibromyalgia is a chronic, heterogeneous pain condition primarily driven by sensitization of the central nervous system (CNS).

What’s driving growth in immuno-oncology?
Immuno-oncology (IO) is one of the fastest-growing segments, widely seen as revolutionizing medical oncology.